About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Managing Resectable Pancreatic Cancer - From Resection to Adjuvant Chemotherapy
By
12th ESO-EONS Masterclass in Oncology Nursing
FEATURING
Florian Lordick
By
12th ESO-EONS Masterclass in Oncology Nursing
FEATURING
Florian Lordick
0 views
June 7, 2019
Comments
0
Login to view comments.
Click here to Login
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Recommended
AUTOPLAY
ON
Related
Newest
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
27:04
Fengting Yan
Cancer Screening Molecular Tools
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
09:01
Integrity CE
Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …
Feat.
L. Zheng
12:50
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…
Feat.
E. Dotan
10:22
Houston Methodist Hospital
mRNA Vaccine in Treatment of Pancreatic Cancer
Feat.
J. Gonzalez
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
08:34
Yale Cancer Center
NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …
Feat.
J. Lacy
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…
Feat.
Y. Janjigian,
S. Cytryn,
S. Maron
31:40
Horizon CME
Updates in Perioperative Therapy of Pancreatic Cancer
Feat.
P. Philip
13:47
Aditya Shreenivas
Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…
Feat.
S. Chakrabarti
17:05
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinic…
Feat.
S. Cohen
07:42
Integrity CE
Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …
Feat.
W. Burns
06:03
Total Health
2024 Updates on Targeted Approaches for GI Cancers and New Data in N…
Feat.
A. Grothey
19:41
Balazs Halmos
How I Manage Immune Adverse Events in Solid Tumors
17:02
Harshabad Singh
Targeting KRAS in Pancreatic Cancer
03:50
UCLA Health
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…
Feat.
Z. Wainberg
04:25
ecancer
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRI…
Feat.
J. Knox
